Cargando…

May critical molecular cross-talk between indoleamine 2,3-dioxygenase (IDO) and arginase during human aging be targets for immunosenescence control?

BACKGROUND: This study aimed to identify novel plasma metabolic signatures with possible clinical relevance during the aging process. A biochemical quantitative phenotyping platform, based on targeted electrospray ionization tandem mass spectrometry technology, was used for the identification of any...

Descripción completa

Detalles Bibliográficos
Autores principales: da Silva, Ismael Dale Cotrim Guerreiro, Marchioni, Dirce Maria Lobo, Carioca, Antonio Augusto Ferreira, Bueno, Valquiria, Colleoni, Gisele Wally Braga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361614/
https://www.ncbi.nlm.nih.gov/pubmed/34389039
http://dx.doi.org/10.1186/s12979-021-00244-x
_version_ 1783737980528099328
author da Silva, Ismael Dale Cotrim Guerreiro
Marchioni, Dirce Maria Lobo
Carioca, Antonio Augusto Ferreira
Bueno, Valquiria
Colleoni, Gisele Wally Braga
author_facet da Silva, Ismael Dale Cotrim Guerreiro
Marchioni, Dirce Maria Lobo
Carioca, Antonio Augusto Ferreira
Bueno, Valquiria
Colleoni, Gisele Wally Braga
author_sort da Silva, Ismael Dale Cotrim Guerreiro
collection PubMed
description BACKGROUND: This study aimed to identify novel plasma metabolic signatures with possible clinical relevance during the aging process. A biochemical quantitative phenotyping platform, based on targeted electrospray ionization tandem mass spectrometry technology, was used for the identification of any eventual perturbed biochemical pathway by the aging process in prospectively collected peripheral blood plasma from 166 individuals representing the population of São Paulo city, Brazil. RESULTS: Indoleamine 2,3-dioxygenase (IDO) activity (Kyn/Trp) was significantly elevated with age, and among metabolites most associated with elevations in IDO, one of the strongest correlations was with arginase (Orn/Arg), which could also facilitate the senescence process of the immune system. Hyperactivity of IDO was also found to correlate with increased blood concentrations of medium-chain acylcarnitines, suggesting that deficiencies in beta-oxidation may also be involved in the immunosenescence process. Finally, our study provided evidence that the systemic methylation status was significantly increased and positively correlated to IDO activity. CONCLUSIONS: In the present article, besides identifying elevated IDO activity exhibiting striking parallel association with the aging process, we additionally identified increased arginase activity as an underlying biochemical disturbance closely following elevations in IDO. Our findings support interventions to reduce IDO or arginase activities in an attempt to preserve the functionality of the immune system, including modulation of myeloid-derived suppressor cells (MDSCs), T cells, macrophages, and dendritic cells’ function, in old individuals/patients.
format Online
Article
Text
id pubmed-8361614
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-83616142021-08-16 May critical molecular cross-talk between indoleamine 2,3-dioxygenase (IDO) and arginase during human aging be targets for immunosenescence control? da Silva, Ismael Dale Cotrim Guerreiro Marchioni, Dirce Maria Lobo Carioca, Antonio Augusto Ferreira Bueno, Valquiria Colleoni, Gisele Wally Braga Immun Ageing Research BACKGROUND: This study aimed to identify novel plasma metabolic signatures with possible clinical relevance during the aging process. A biochemical quantitative phenotyping platform, based on targeted electrospray ionization tandem mass spectrometry technology, was used for the identification of any eventual perturbed biochemical pathway by the aging process in prospectively collected peripheral blood plasma from 166 individuals representing the population of São Paulo city, Brazil. RESULTS: Indoleamine 2,3-dioxygenase (IDO) activity (Kyn/Trp) was significantly elevated with age, and among metabolites most associated with elevations in IDO, one of the strongest correlations was with arginase (Orn/Arg), which could also facilitate the senescence process of the immune system. Hyperactivity of IDO was also found to correlate with increased blood concentrations of medium-chain acylcarnitines, suggesting that deficiencies in beta-oxidation may also be involved in the immunosenescence process. Finally, our study provided evidence that the systemic methylation status was significantly increased and positively correlated to IDO activity. CONCLUSIONS: In the present article, besides identifying elevated IDO activity exhibiting striking parallel association with the aging process, we additionally identified increased arginase activity as an underlying biochemical disturbance closely following elevations in IDO. Our findings support interventions to reduce IDO or arginase activities in an attempt to preserve the functionality of the immune system, including modulation of myeloid-derived suppressor cells (MDSCs), T cells, macrophages, and dendritic cells’ function, in old individuals/patients. BioMed Central 2021-08-13 /pmc/articles/PMC8361614/ /pubmed/34389039 http://dx.doi.org/10.1186/s12979-021-00244-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
da Silva, Ismael Dale Cotrim Guerreiro
Marchioni, Dirce Maria Lobo
Carioca, Antonio Augusto Ferreira
Bueno, Valquiria
Colleoni, Gisele Wally Braga
May critical molecular cross-talk between indoleamine 2,3-dioxygenase (IDO) and arginase during human aging be targets for immunosenescence control?
title May critical molecular cross-talk between indoleamine 2,3-dioxygenase (IDO) and arginase during human aging be targets for immunosenescence control?
title_full May critical molecular cross-talk between indoleamine 2,3-dioxygenase (IDO) and arginase during human aging be targets for immunosenescence control?
title_fullStr May critical molecular cross-talk between indoleamine 2,3-dioxygenase (IDO) and arginase during human aging be targets for immunosenescence control?
title_full_unstemmed May critical molecular cross-talk between indoleamine 2,3-dioxygenase (IDO) and arginase during human aging be targets for immunosenescence control?
title_short May critical molecular cross-talk between indoleamine 2,3-dioxygenase (IDO) and arginase during human aging be targets for immunosenescence control?
title_sort may critical molecular cross-talk between indoleamine 2,3-dioxygenase (ido) and arginase during human aging be targets for immunosenescence control?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361614/
https://www.ncbi.nlm.nih.gov/pubmed/34389039
http://dx.doi.org/10.1186/s12979-021-00244-x
work_keys_str_mv AT dasilvaismaeldalecotrimguerreiro maycriticalmolecularcrosstalkbetweenindoleamine23dioxygenaseidoandarginaseduringhumanagingbetargetsforimmunosenescencecontrol
AT marchionidircemarialobo maycriticalmolecularcrosstalkbetweenindoleamine23dioxygenaseidoandarginaseduringhumanagingbetargetsforimmunosenescencecontrol
AT cariocaantonioaugustoferreira maycriticalmolecularcrosstalkbetweenindoleamine23dioxygenaseidoandarginaseduringhumanagingbetargetsforimmunosenescencecontrol
AT buenovalquiria maycriticalmolecularcrosstalkbetweenindoleamine23dioxygenaseidoandarginaseduringhumanagingbetargetsforimmunosenescencecontrol
AT colleonigiselewallybraga maycriticalmolecularcrosstalkbetweenindoleamine23dioxygenaseidoandarginaseduringhumanagingbetargetsforimmunosenescencecontrol